Respreeza® Self-administration and Learning Program (AmAREtTI Study)

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

May 6, 2024

Study Completion Date

May 6, 2024

Conditions
Alpha-1 Antitrypsin Deficiency
Trial Locations (11)

Unknown

CHU Angers, Angers

CHU Bordeaux - Hôpital Haut-Lévèque, Bordeaux

CHU Grenoble-Alpes, Grenoble

CHU Lille, Lille

Hospices Civils de Lyon, Lyon

Hôpital Saint Joseph, Marseille

Hôpital Bichat-Claude-Bernard, Paris

CHU Rennes - Hôpital Pontchaillou, Rennes

CHU Strasbourg, Strasbourg

CHRU Tours, Tours

CHU Nancy Brabois, Vandœuvre-lès-Nancy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY